BevacizumabReversible posterior leukoencephalopathy syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2008年 / 1221卷 / 1期

关键词：

Potassium; Colorectal Cancer; Protein Level; Patient Outcome; Bevacizumab;

D O I：

10.2165/00128415-200812210-00026

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：9 / 9

相关论文

共 50 条

[1] BevacizumabReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2011, 1357 (1) : 9 - 9
[2] BevacizumabReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2018, 1729 (1) : 50 - 50
[3] BevacizumabReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2008, 1213 (1) : 11 - 11
[4] BevacizumabReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2011, 1381 (1) : 7 - 7
[5] BevacizumabReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2008, 1198 (1) : 10 - 10
[6] BevacizumabReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2006, 1128 (1) : 8 - 8
[7] BevacizumabReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2014, 1504 (1) : 7 - 7
[8] BevacizumabReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2009, 1264 (1) : 9 - 9
[9] BevacizumabReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2020, 1820 (1) : 71 - 71
[10] BevacizumabReversible posterior leukoencephalopathy syndrome in a child: case report
[J]. Reactions Weekly, 2009, 1261 (1) : 8 - 8

← 1 2 3 4 5 →